title: In silico molecular comparisons of C. elegans and mammalian pharmacology identify distinct targets that regulate feeding.
abstract: Phenotypic screens can identify molecules that are at once penetrant and active on the integrated circuitry of a whole cell or organism. These advantages are offset by the need to identify the targets underlying the phenotypes. Additionally, logistical considerations limit screening for certain physiological and behavioral phenotypes to organisms such as zebrafish and C. elegans. This further raises the challenge of elucidating whether compound-target relationships found in model organisms are preserved in humans. To address these challenges we searched for compounds that affect feeding behavior in C. elegans and sought to identify their molecular mechanisms of action. Here, we applied predictive chemoinformatics to small molecules previously identified in a C. elegans phenotypic screen likely to be enriched for feeding regulatory compounds. Based on the predictions, 16 of these compounds were tested in vitro against 20 mammalian targets. Of these, nine were active, with affinities ranging from 9 nM to 10 µM. Four of these nine compounds were found to alter feeding. We then verified the in vitro findings in vivo through genetic knockdowns, the use of previously characterized compounds with high affinity for the four targets, and chemical genetic epistasis, which is the effect of combined chemical and genetic perturbations on a phenotype relative to that of each perturbation in isolation. Our findings reveal four previously unrecognized pathways that regulate feeding in C. elegans with strong parallels in mammals. Together, our study addresses three inherent challenges in phenotypic screening: the identification of the molecular targets from a phenotypic screen, the confirmation of the in vivo relevance of these targets, and the evolutionary conservation and relevance of these targets to their human orthologs.
authors.affiliation: Department of Anatomy, University of California, San Francisco, California, United States of America.
authors.forename: George A
authors.initials: GA
authors.lastname: Lemieux
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Keiser
authors.forename: Maria F
authors.initials: MF
authors.lastname: Sassano
authors.forename: Christian
authors.initials: C
authors.lastname: Laggner
authors.forename: Fahima
authors.initials: F
authors.lastname: Mayer
authors.forename: Roland J
authors.initials: RJ
authors.lastname: Bainton
authors.forename: Zena
authors.initials: Z
authors.lastname: Werb
authors.forename: Bryan L
authors.initials: BL
authors.lastname: Roth
authors.forename: Brian K
authors.initials: BK
authors.lastname: Shoichet
authors.forename: Kaveh
authors.initials: K
authors.lastname: Ashrafi
mesh_terms: D000818:Animals; D017173:Caenorhabditis elegans / Q000187:drug effects* / Q000502:physiology; D029742:Caenorhabditis elegans Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D003198:Computer Simulation; D004353:Drug Evaluation, Preclinical; D005247:Feeding Behavior / Q000187:drug effects*; D006801:Humans; D010528:Peristalsis / Q000187:drug effects; D010614:Pharynx / Q000187:drug effects; D010641:Phenotype; D011804:Quinolines / Q000494:pharmacology; D043562:Receptors, G-Protein-Coupled / Q000037:antagonists & inhibitors / Q000378:metabolism; D054852:Small Molecule Libraries
chemical_list: D029742:Caenorhabditis elegans Proteins; D011804:Quinolines; D043562:Receptors, G-Protein-Coupled; C109112:SB 222200; D054852:Small Molecule Libraries